all report title image

Seasonal Influenza Vaccines Market, By Vaccine Type (Quadrivalent, Trivalent, Cell-based, Recombinant, Others), By Age Group (Pediatric, Adult, Geriatric, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Public Health Programs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : May 2026
  • Code : CMI1604
  • Formats :
      Excel and PDF
  • Industry : Biotechnology
  • 역사적 분포 범위 : 2020 - 2024
  • 기준 연도 : 2025
  • 예상 연도 : 2026
  • 예측 기간 : 2026 - 2033
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    1. Research Objectives

    2. Assumptions

    3. Abbreviations

  2. Market Preview

    1. Report Description

      1. Market Definition and Scope

    2. Executive Summary

      1. Market Snapshot, By Vaccine Type

      2. Market Snapshot, By Age Group

      3. Market Snapshot, By Distribution Channel

      4. Market Snapshot, By Region

    3. Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    1. Market Dynamics

      1. Drivers

      2. Restraints

      3. Market Opportunities

    2. Impact Analysis

    3. Recent Product Launches

    4. Epidemiology

    5. Merger, Acquisition, and Collaboration

    6. Regulatory Scenario

    7. Key Developments

    8. PEST Analysis

    9. Partnership Scenario

    10. Brand and Pricing Analysis

    11. Distributors Landscape

    12. Porters Analysis

    13. Technological Advancements

    14. Key Developments

    15. Market Trend

    16. Future Prospective

    17. Top Market Players by Revenue

  4. Seasonal Influenza Vaccines Market By Vaccine Type, 2026–2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Quadrivalent

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Trivalent

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Cell-based

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Recombinant

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    6. Others

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  5. Seasonal Influenza Vaccines Market By Age Group, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Pediatric

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Adult

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Geriatric

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Others

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  6. Seasonal Influenza Vaccines Market By Distribution Channel, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Hospital Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Retail Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Online Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Public Health Programs

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    6. Others

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  7. Seasonal Influenza Vaccines Market By Region, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, By Region, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, For Regions, 2022–2033

      3. Regional Trends

    2. North America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.S.

        2. Canada

    3. Latin America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

    4. Europe

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.K.

        2. Germany

        3. Italy

        4. France

        5. Spain

        6. Russia

        7. Benelux

        8. Denmark

        9. Norway

        10. Sweden

        11. Rest of Europe

    5. Asia Pacific

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. China

        2. Taiwan

        3. India

        4. Japan

        5. Indonesia

        6. Malaysia

        7. Philippines

        8. Singapore

        9. Australia

        10. South Korea

        11. Rest of Asia Pacific

o    Middle East & Africa

  1. Introduction

  2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

  3. Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2026-2033, (US$ Billion)

  4. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

  5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

    1. Bahrain

    2. Kuwait

    3. Oman

    4. Qatar

    5. Saudi Arabia

    6. UAE

    7. Israel

    8. South Africa

    9. North Africa

    10. Central Africa

    11. Rest of the Middle East

  1. Competitive Landscape

    • Sanofi

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • GlaxoSmithKline

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • AstraZeneca

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Serum Institute of India

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Moderna

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Seqirus

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bharat Biotech

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Novavax

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Valneva

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Pfizer

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

9.Section

  • Research Methodology

  • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.